{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:02:36Z","timestamp":1781103756275,"version":"3.54.1"},"publisher-location":"Cham","reference-count":53,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030663056","type":"print"},{"value":"9783030663063","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_272","type":"book-chapter","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T10:03:39Z","timestamp":1573034619000},"page":"265-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Use of Botulinum Toxin for Treatment of Depression"],"prefix":"10.1007","author":[{"given":"M. Axel","family":"Wollmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Magid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tillmann H. C.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Finzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"272_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev.ps.40.020189.001341","volume":"40","author":"PK Adelmann","year":"1989","unstructured":"Adelmann PK, Zajonc RB (1989) Facial efference and the experience of emotion. Annu Rev Psychol 40:249\u2013280","journal-title":"Annu Rev Psychol"},{"key":"272_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.mehy.2011.08.044","volume":"77","author":"T Al Abdulmohsen","year":"2011","unstructured":"Al Abdulmohsen T, Kruger TH (2011) The contribution of muscular and auditory pathologies to the symptomatology of autism. Med Hypotheses 77:1038\u20131047","journal-title":"Med Hypotheses"},{"key":"272_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-017-0723-4","volume":"18","author":"EI Aydinlar","year":"2017","unstructured":"Aydinlar EI, Dikmen PY, Kosak S et al (2017) OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study. J Headache Pain 18:23","journal-title":"J Headache Pain"},{"key":"272_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.toxicon.2016.04.044","volume":"118","author":"JC Baumeister","year":"2016","unstructured":"Baumeister JC, Papa G, Foroni F (2016) Deeper than skin deep \u2013 the effect of botulinum toxin-A on emotion processing. Toxicon 118:86\u201390","journal-title":"Toxicon"},{"key":"272_CR5","first-page":"27","volume":"9","author":"K Beer","year":"2010","unstructured":"Beer K (2010) Cost effectiveness of botulinum toxins for the treatment of depression: preliminary observations. J Drugs Dermatol 9:27\u201330","journal-title":"J Drugs Dermatol"},{"key":"272_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/IJGM.S70456","volume":"9","author":"GP Boudreau","year":"2015","unstructured":"Boudreau GP, Grosberg BM, McAllister PJ et al (2015) Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: an open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety. Int J Gen Med 9:79\u201386","journal-title":"Int J Gen Med"},{"key":"272_CR7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","volume":"61","author":"MF Brin","year":"2009","unstructured":"Brin MF, Boodhoo TI, Pogoda JM et al (2009) Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol 61:961\u2013970","journal-title":"J Am Acad Dermatol"},{"key":"272_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.toxicon.2008.12.026","volume":"54","author":"M Caleo","year":"2009","unstructured":"Caleo M, Schiavo G (2009) Central effects of tetanus and botulinum neurotoxins. Toxicon 54:593\u2013599","journal-title":"Toxicon"},{"issue":"Suppl 1","key":"272_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/17429590701523927","volume":"9","author":"A Carruthers","year":"2007","unstructured":"Carruthers A, Cohen JL, Cox SE et al (2007) Facial aesthetics: achieving the natural, relaxed look. J Cosmet Laser Ther 9(Suppl 1):6\u201310","journal-title":"J Cosmet Laser Ther"},{"key":"272_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neubiorev.2013.11.002","volume":"38","author":"L Cattaneo","year":"2014","unstructured":"Cattaneo L, Pavesi G (2014) The facial motor system. Neurosci Biobehav Rev 38:135\u2013159","journal-title":"Neurosci Biobehav Rev"},{"key":"272_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PRA.0000000000000277","volume":"24","author":"S Chugh","year":"2018","unstructured":"Chugh S, Chhabria A, Jung S et al (2018) Botulinum toxin as a treatment for depression in a real-world setting. J Psychiatr Pract 24:15\u201320","journal-title":"J Psychiatr Pract"},{"key":"272_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jpra.2017.01.005","volume":"12","author":"JL Cobo","year":"2017","unstructured":"Cobo JL, Sole-Magdalena A, Menendez I et al (2017) Connections between the facial and trigeminal nerves: anatomical basis for facial muscle proprioception. JPRAS Open 12:9\u201318","journal-title":"JPRAS Open"},{"key":"272_CR13","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41598-017-01590-x","volume":"7","author":"IV Cohen","year":"2017","unstructured":"Cohen IV, Makunts T, Atayee R et al (2017) Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. Sci Rep 7:1450","journal-title":"Sci Rep"},{"key":"272_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1037\/bul0000194","volume":"145","author":"NA Coles","year":"2019","unstructured":"Coles NA, Larsen JT, Lench HC (2019) A meta-analysis of the facial feedback literature: effects of facial feedback on emotional experience are small and variable. Psychol Bull 145:610\u2013651","journal-title":"Psychol Bull"},{"key":"272_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1037\/a0018690","volume":"10","author":"JI Davis","year":"2010","unstructured":"Davis JI, Senghas A, Brandt F et al (2010) The effects of BOTOX injections on emotional experience. Emotion 10:433\u2013440","journal-title":"Emotion"},{"key":"272_CR16","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s10072-016-2665-z","volume":"37","author":"BE Demiryurek","year":"2016","unstructured":"Demiryurek BE, Ertem DH, Tekin A et al (2016) Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine. Neurol Sci 37:1779\u20131784","journal-title":"Neurol Sci"},{"key":"272_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, RE DG, PREEMPT Chronic Migraine Study Group et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50:921\u2013936","journal-title":"Headache"},{"key":"272_CR18","volume-title":"Facial action coding system: a technique for the measurement of facial movement","author":"P Ekman","year":"1978","unstructured":"Ekman P, Friesen WV (1978) Facial action coding system: a technique for the measurement of facial movement. Consulting Psychologists Press, Palo Alto"},{"key":"272_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.6612338","volume":"212","author":"P Ekman","year":"1983","unstructured":"Ekman P, Levenson PW, Friesen WV (1983) Autonomic nervous system activity distinguishes among emotions. Science 212:1208\u20131210","journal-title":"Science"},{"key":"272_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi E, Rosenthal NE (2014) Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res 52:1\u20136","journal-title":"J Psychiatr Res"},{"key":"272_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpsychires.2016.06.009","volume":"80","author":"E Finzi","year":"2016","unstructured":"Finzi E, Rosenthal NE (2016) Emotional proprioception: treatment of depression with afferent facial feedback. J Psychiatr Res 80:93\u201396","journal-title":"J Psychiatr Res"},{"key":"272_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/JCP.0000000000001066","volume":"39","author":"E Finzi","year":"2019","unstructured":"Finzi E, Rosenthal NE (2019) Botulinum toxin therapy of social anxiety disorder: a case series. J Clin Psychopharmacol 39:410\u2013412","journal-title":"J Clin Psychopharmacol"},{"key":"272_CR23","first-page":"645","volume":"32","author":"E Finzi","year":"2006","unstructured":"Finzi E, Wasserman E (2006) Treatment of depression with botulinum toxin A: a case series. Dermatol Surg 32:645\u2013649","journal-title":"Dermatol Surg"},{"key":"272_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpsychires.2018.06.015","volume":"104","author":"E Finzi","year":"2018","unstructured":"Finzi E, Kels L, Axelowitz J et al (2018) Botulinum toxin therapy of bipolar depression: a case series. J Psychiatr Res 104:55\u201357","journal-title":"J Psychiatr Res"},{"key":"272_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nm.3090","volume":"19","author":"SA Golden","year":"2013","unstructured":"Golden SA, Christoffel DJ, Heshmati M et al (2013) Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med 19:337\u2013344","journal-title":"Nat Med"},{"key":"272_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1176\/ajp.142.3.348","volume":"142","author":"JF Greden","year":"1985","unstructured":"Greden JF, Genero N, Price HL (1985) Agitation-increased electromyogram activity in the corrugator muscle region: a possible explanation of the \u201cOmega sign\u201d? Am J Psychiatry 142:348\u2013351","journal-title":"Am J Psychiatry"},{"key":"272_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s10194-016-0634-9","volume":"17","author":"S Guerzoni","year":"2015","unstructured":"Guerzoni S, Pellesi L, Baraldi C et al (2015) Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment. J Headache Pain 17:48","journal-title":"J Headache Pain"},{"key":"272_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fneur.2017.00586","volume":"8","author":"S Guerzoni","year":"2017","unstructured":"Guerzoni S, Pellesi L, Baraldi C et al (2017) Long-term treatment benefits and prolonged efficacy of OnabotulinumtoxinA in patients affected by chronic migraine and medication overuse headache over 3 years of therapy. Front Neurol 8:586","journal-title":"Front Neurol"},{"key":"272_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1177\/0956797610374742","volume":"21","author":"DA Havas","year":"2010","unstructured":"Havas DA, Glenberg AM, Gutowski KA et al (2010) Cosmetic use of botulinum toxin-a affects processing of emotional language. Psychol Sci 21:895\u2013900","journal-title":"Psychol Sci"},{"key":"272_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1067\/S0190-9622(03)00909-5","volume":"49","author":"M Heckmann","year":"2003","unstructured":"Heckmann M, Teichmann B, Schroder U et al (2003) Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. J Am Acad Dermatol 49:213\u2013216","journal-title":"J Am Acad Dermatol"},{"key":"272_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cercor\/bhn104","volume":"19","author":"A Hennenlotter","year":"2009","unstructured":"Hennenlotter A, Dresel C, Castrop F et al (2009) The link between facial feedback and neural activity within central circuitries of emotion-new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex 19:537\u2013542","journal-title":"Cereb Cortex"},{"key":"272_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/dsu.12175","volume":"39","author":"D Hexsel","year":"2013","unstructured":"Hexsel D, Brum C, Siega C et al (2013) Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxinA for glabellar lines. Dermatol Surg 39:1088\u20131096","journal-title":"Dermatol Surg"},{"key":"272_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2016.02.020","volume":"617","author":"S Ibragi\u0107","year":"2016","unstructured":"Ibragi\u0107 S, Matak I, Dra\u010di\u0107 A et al (2016) Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats. Neurosci Lett 617:213\u2013217","journal-title":"Neurosci Lett"},{"key":"272_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-5380-4-11","volume":"4","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Neta M, Davis FC et al (2014) Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design. Biol Mood Anxiety Disord 4:11","journal-title":"Biol Mood Anxiety Disord"},{"key":"272_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00702-016-1539-0","volume":"123","author":"K Kollewe","year":"2016","unstructured":"Kollewe K, Escher CM, Wulff DU et al (2016) Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting. J Neural Transm 123:533\u2013540","journal-title":"J Neural Transm"},{"key":"272_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.toxicon.2015.09.035","volume":"107","author":"TH Kruger","year":"2015","unstructured":"Kruger TH, Wollmer MA (2015) Depression--an emerging indication for botulinum toxin treatment. Toxicon 107:154\u2013157","journal-title":"Toxicon"},{"key":"272_CR37","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1176\/appi.ajp.2016.16020174","volume":"173","author":"TH Kruger","year":"2016","unstructured":"Kruger TH, Magid M, Wollmer MA (2016) Can botulinum toxin help patients with borderline personality disorder? Am J Psychiatry 173:940\u2013941","journal-title":"Am J Psychiatry"},{"key":"272_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1473-2165.2009.00419.x","volume":"8","author":"MB Lewis","year":"2009","unstructured":"Lewis MB, Bowler PJ (2009) Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 8:24\u201326","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"272_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s12264-019-00367-8","volume":"35","author":"Y Li","year":"2019","unstructured":"Li Y, Liu J, Liu X (2019) Antidepressant-like action of single facial injection of botulinum neurotoxin A is associated with augmented 5-HT levels and BDNF\/ERK\/CREB pathways in mouse brain. Neurosci Bull 35(4):661\u2013672","journal-title":"Neurosci Bull"},{"key":"272_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/head.12657","volume":"55","author":"K Maasumi","year":"2015","unstructured":"Maasumi K, Thompson NR, Kriegler JS (2015) Effect of OnabotulinumtoxinA injection on depression in chronic migraine. Headache 55:1218\u20131224","journal-title":"Headache"},{"key":"272_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid M, Reichenberg JS, Poth PE et al (2014) Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry 75:837\u2013844","journal-title":"J Clin Psychiatry"},{"key":"272_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0035-1559621","volume":"48","author":"M Magid","year":"2015","unstructured":"Magid M, Finzi E, Kruger TH et al (2015) Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Pharmacopsychiatry 48:205\u2013210","journal-title":"Pharmacopsychiatry"},{"key":"272_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","volume":"591","author":"V Marchand-Pauvert","year":"2013","unstructured":"Marchand-Pauvert V, Aymard C, Giboin LS et al (2013) Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A. J Physiol 591:1017\u20131029","journal-title":"J Physiol"},{"key":"272_CR44","doi-asserted-by":"publisher","first-page":"e0134659","DOI":"10.1371\/journal.pone.0134659","volume":"10","author":"K Matsuo","year":"2015","unstructured":"Matsuo K, Ban R, Hama Y et al (2015) Eyelid opening with trigeminal proprioceptive activation regulates a brainstem arousal mechanism. PLoS One 10:e0134659","journal-title":"PLoS One"},{"key":"272_CR45","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/jdv.12881","volume":"29","author":"B Molina","year":"2015","unstructured":"Molina B, Grangier Y, Mole B (2015) Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol 29:1382\u20131388","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"272_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/PRA.0000000000000136","volume":"22","author":"AK Parsaik","year":"2016","unstructured":"Parsaik AK, Mascarenhas SS, Hashmi A et al (2016) Role of botulinum toxin in depression. J Psychiatr Pract 22:99\u2013110","journal-title":"J Psychiatr Pract"},{"key":"272_CR47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1257786","volume":"192","author":"GE Schwartz","year":"1976","unstructured":"Schwartz GE, Fair PL, Salt P et al (1976) Facial muscle patterning to affective imagery in depressed and nondepressed subjects. Science 192:489\u2013491","journal-title":"Science"},{"key":"272_CR48","first-page":"456","volume":"29","author":"B Sommer","year":"2003","unstructured":"Sommer B, Zschocke I, Bergfeld D et al (2003) Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg 29:456\u2013460","journal-title":"Dermatol Surg"},{"key":"272_CR49","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","volume":"46","author":"MA Wollmer","year":"2012","unstructured":"Wollmer MA, de Boer C, Kalak N et al (2012) Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res 46:574\u2013581","journal-title":"J Psychiatr Res"},{"key":"272_CR50","first-page":"36","volume":"5","author":"MA Wollmer","year":"2014","unstructured":"Wollmer MA, Kalak N, Jung S et al (2014) Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial. Front Psych 5:36","journal-title":"Front Psych"},{"key":"272_CR51","first-page":"540","volume":"153","author":"MA Wollmer","year":"2018","unstructured":"Wollmer MA, Neumann I, Magid M et al (2018) Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry. G Ital Dermatol Venereol 153:540\u2013548","journal-title":"G Ital Dermatol Venereol"},{"key":"272_CR52","first-page":"982","volume":"46","author":"A Zamanian","year":"2017","unstructured":"Zamanian A, Ghanbari Jolfaei A, Mehran G et al (2017) Efficacy of botox versus placebo for treatment of patients with major depression. Iran J Public Health 46:982\u2013984","journal-title":"Iran J Public Health"},{"key":"272_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/00207454.2016.1196687","volume":"127","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhang H, Wei Y et al (2017) Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study. Int J Neurosci 127:285\u2013290","journal-title":"Int J Neurosci"}],"updated-by":[{"DOI":"10.1007\/164_2020_411","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000}}],"container-title":["Handbook of Experimental Pharmacology","Botulinum Toxin Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T19:31:36Z","timestamp":1609875096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030663056","9783030663063"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/164_2019_272","relation":{"correction":[{"id-type":"doi","id":"10.1007\/164_2020_411","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"4 December 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The chapter was inadvertently published without a more specific title according to SEO guidelines. A chapter title needs to be understandable when seen as a stand-alone item, e.g. on PubMed. The chapter title has now been corrected as \u2018The Use of Botulinum Toxin for Treatment of Depression\u2019.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}